250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study by O'Connor, Paul, MD, Filippi, Massimo, MD, Arnason, Barry, MD, Comi, Giancarlo, MD, Cook, Stuart, MD, Goodin, Douglas, MD, Hartung, Hans-Peter, MD, Jeffery, Douglas, MD, Kappos, Ludwig, MD, Boateng, Francis, PhD, Filippov, Vitali, PhD, Groth, Maria, MD, Knappertz, Volker, MD, Kraus, Christian, MD, Sandbrink, Rupert, MD, Pohl, Christoph, MD, Bogumil, Timon, MD

Get full text

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT... by Kappos, Ludwig, MD, Freedman, Mark S, MD, Polman, Chris H, MD, Edan, Gilles, MD, Hartung, Hans-Peter, MD, Miller, David H, MD, Montalbán, Xavier, MD, Barkhof, Frederik, MD, Radü, Ernst-Wilhelm, MD, Metzig, Carola, MD, Bauer, Lars, MD, Lanius, Vivian, PhD, Sandbrink, Rupert, MD, Pohl, Christoph, MD

Get full text

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT... by Kappos, Ludwig, Prof, Freedman, Mark S, Prof, Polman, Chris H, Prof, Edan, Gilles, Prof, Hartung, Hans-Peter, Prof, Miller, David H, Prof, Montalbán, Xavier, Prof, Barkhof, Frederik, Prof, Radü, Ernst-Wilhelm, Prof, Bauer, Lars, MD, Dahms, Susanne, PhD, Lanius, Vivian, PhD, Pohl, Christoph, MD, Sandbrink, Rupert, MD

Get full text

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score by De Jager, Philip L, MD, Chibnik, Lori B, PhD, Cui, Jing, PhD, Reischl, Joachim, PhD, Lehr, Stephan, PhD, Simon, K Claire, PhD, Aubin, Cristin, BS, Bauer, David, PhD, Heubach, Jürgen F, MD, Sandbrink, Rupert, MD, Tyblova, Michaela, MD, Lelkova, Petra, MD, Havrdova, Eva, MD, Pohl, Christoph, MD, Horakova, Dana, MD, Ascherio, Alberto, MD, Hafler, David A, MD, Karlson, Elizabeth W, MD

Get full text

Cost-Effectiveness Analysis of Interferon Beta-1b for the Treatment of Patients With a First Clinical Event Suggestive of Multiple Sclerosis by Caloyeras, John P., MPhil, Zhang, Bin, MD, MSc, Wang, Cheng, MD, PhD, Eriksson, Marianne, MSc, Fredrikson, Sten, MD, PhD, Beckmann, Karola, MSc, Knappertz, Volker, MD, Pohl, Christoph, MD, Hartung, Hans-Peter, MD, Shah, Dhvani, MS, Miller, Jeffrey D., MS, Sandbrink, Rupert, MD, Lanius, Vivian, PhD, Gondek, Kathleen, PhD, Russell, Mason W., MAPE

Get full text

Randomized Comparison of Percutaneous Coronary Intervention With Sirolimus-Eluting Stents Versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis by Boudriot, Enno, MD, Thiele, Holger, MD, Walther, Thomas, MD, Liebetrau, Christoph, MD, Boeckstegers, Peter, MD, Pohl, Tilmann, MD, Reichart, Bruno, MD, Mudra, Harald, MD, Beier, Florian, MD, Gansera, Brigitte, MD, Neumann, Franz-Josef, MD, Gick, Michael, MD, Zietak, Thomas, MD, Desch, Steffen, MD, Schuler, Gerhard, MD, Mohr, Friedrich-Wilhelm, MD

Get full text